roundhill glp 1 & weight loss etf New funds jump on trade Transformative health innovation meets smart

Description

In receptor binding studies, the affinity of tirzepatide was comparable to that of native GIP for the GIP receptor and approximately fivefold weaker than that of native GLP-1 for the GLP-1 receptor [88]

Yes, it is FDA-approved and shown to be safe when used under medical supervision

doi: 10.1002/jnr.22565 [DOI] [PubMed] [Google Scholar] 167

doi: 10.1210/jcem.84.7.5864

actual product may vary US Name: Januvia Alternative Names: Januvia Active Ingredients: Sitagliptin Brand Manufacturer: MSD Manufacturer Location: Italy Click here to view Product Insert Click here to view Product Insert For visual reference only